Expandable Introducer Sheath

Through the design of negative Poisson's sheath tube and stent-like frame, local radial expansion and surface elongation are achieved when delivering catheters or implants, keeping the sheath tube length unchanged, and solving the sheath tube length in the prior art Change and compression force issues improve delivery efficiency and safety.

CN112804970BActive Publication Date: 2024-11-05EDWARDS LIFESCIENCES CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN201980064011.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2019-09-26
Filing Date
2019-09-30
Publication Date
2024-11-05
Estimated Expiration
2039-09-30

AI Technical Summary

Technical Problem

The existing expandable sheaths when delivering catheters or implants, local radial expansion results in a change in the overall length of the sheath, increasing the difficulty of propulsion and anatomical pressure on the patient, and failing to effectively reduce the compression force on the catheter.

Method used

A sheath with a negative Poisson ratio was designed to achieve proportional responses of local radial expansion and surface elongation through the bracket-like frame, keeping the overall length of the sheath constant, reducing the propulsion resistance, and causing it by longitudinal tensile force. Local surface elongation and radial expansion reduce the need for propulsion.

Benefits of technology

Effectively reduces the overall force required to push the catheter or implant through the sheath, reduces the complexity of the procedure and the force of the patient's anatomy, and improves delivery efficiency and safety.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN112804970B_ABST
    Figure CN112804970B_ABST
Patent Text Reader

Abstract

A system for delivering medical implants has an expandable introducer sheath that can be locally expanded and elongated to accommodate the passage of a delivery catheter and an implant such as a prosthetic heart valve secured to a balloon catheter. The expandable sheath can be configured so that the local expansion is proportional to the local surface elongation.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0002] This application claims priority to U.S. Provisional Patent Application No. 62 / 740,690, filed on October 3, 2018, which is incorporated herein by reference in its entirety. Technical Field

[0003] The present invention relates to systems and methods for delivering and deploying medical implants, such as prosthetic heart valves, and more particularly to methods and apparatus utilizing an expandable sheath to accommodate implant delivery. Background Art

[0004] Catheter systems (e.g., treatment catheters, delivery catheters, and / or deployment catheters) are used to treat patients internally. For example, delivery catheter systems are used to deliver and deploy prosthetic devices (e.g., prosthetic heart valves) at locations within the body. Using transcatheter techniques, prosthetic heart valves can be delivered to treatment sites within a patient's body (e.g., aortic, mitral, tricuspid, and / or pulmonary valve locations).

[0005] Introducer sheath can be used to utilize various approaches (such as via the femoral approach of the femoral artery) to safely introduce a delivery device (such as a delivery catheter) into the patient's vascular system. This introducer sheath protects local tissue and facilitates the introduction of the delivery catheter in the patient. General introducer sheath generally has an elongated sleeve and a housing, which is inserted into the vascular system, and the housing is left outside the patient's body and comprises one or more sealing valves (sealing valves, sealing valves), which minimize blood loss outside the sheath when the delivery device is advanced into the patient via the elongated sleeve and the housing.

[0006] Conventional methods of accessing a blood vessel, such as the femoral artery, prior to introducing a delivery system include dilating the vessel using multiple dilators or sheaths of increasing diameter. This repeated insertion and vessel dilation can increase the amount of time required for the procedure as well as the risk of vessel injury.

[0007] Radially expanded access sheaths are known in the art. Such sheaths may have complex mechanisms, such as a ratchet mechanism that maintains the sheath in an expanded configuration after a device having a diameter greater than the original diameter of the sheath is introduced. Other sheaths can be elastically deformed, and can be temporarily radially expanded in an elastic manner in response to the outward pressure caused by a delivery catheter or other device when it passes through the sheath. Some of these sheaths will elastically deform / radially expand in a local area when the wider portion of the delivery catheter passes therethrough, and then retract to a smaller (e.g., original) diameter when the wider portion of the delivery system has passed through this specific portion of the sheath. However, local radial expansion can cause the sheath to change in total length, which can cause the portion of the sheath to change its position in the patient's vascular system. In addition, current expandable sheath technology cannot alleviate the compression along the entire length of the delivery catheter body, and can actually increase the compressive force of the sheath when the sheath is expanded. These compressive forces can interfere with the advancement of the catheter / implant through the sheath, and / or require high delivery forces to advance the catheter / implant through the sheath.

[0008] There is a need for a delivery sheath that can locally expand radially to accommodate a delivery catheter / device without causing a change in the overall length of the sheath. There is also a need for a delivery sheath that relieves compression of a larger delivery catheter as it passes through the sheath body. The present invention meets these needs. Summary of the invention

[0009] The present invention provides systems, devices and methods for accessing a patient's body using an access sheath and a delivery / deployment / treatment catheter, such as may be desired during a heart valve implantation procedure (eg, transcatheter heart valve delivery).

[0010] In one embodiment, the sheath is configured to locally extend and locally extend in proportion to the corresponding local radial expansion in response to the corresponding local radial expansion, and / or on the contrary, that is, locally extend and locally extend in proportion to the corresponding local surface extension in response to the corresponding local surface extension. The local surface extension allows the sheath overall length to remain constant during the local radial expansion process. The local radial expansion causes the larger diameter lumen that can adapt to larger structures, and the compression force that can be reduced to the catheter and / or implant passing the sheath can also be achieved. The local surface extension can preferably occur directly in response to the local radial expansion, without applying any other force (except the force (one or more) that causes the local radial expansion). The local radial expansion can preferably occur directly in response to the local surface extension, without applying any other force (except the force (one or more) that causes the local surface extension).

[0011] The sheath of the present invention can present a negative Poisson's ratio. In existing expandable sheaths, the behavior of passing the delivery catheter in the sheath causes the sheath to expand radially, and causes the sheath to increase the compression force on the delivery catheter, generally resulting in the need for increased insertion force to advance the catheter through the sheath. In contrast, the sheath of the present invention has a negative Poisson's ratio, wherein the radial expansion of the sheath (which can be caused by longitudinal tensile force and / or radial expansion force) causes the compression force from the sheath to decrease when the sheath expands. The reduction in compression force during radial expansion causes the internal resistance of the sheath that resists the advancement of the catheter / implant through the sheath to decrease. This reduces the overall force required to introduce and advance the delivery catheter / implant through the sheath, and can help reduce procedural complexity, and also reduces the force imposed on the patient's anatomical structure during the procedure.

[0012] The sheath can be preferably configured so that radial expansion and elongation are proportional to each other and interconnected, such as wherein radial expansion is proportional to local surface elongation, and / or wherein local surface elongation is proportional to radial expansion. The radial expansion can be caused in whole or in part by the longitudinal tensile force locally along the sheath. For example, advancing the catheter through the sheath can result in a longitudinal tensile force locally to the sheath, which can cause a local surface elongation, which in turn causes a local radial expansion. The elongation can be caused in whole or in part by a radially outward force along the length of the sheath. For example, expanding the device in the sheath can result in a radial expansion force locally to the sheath, which can cause a radial expansion, which in turn causes a local surface elongation.

[0013] The sheath according to the present invention may include a stent-like framework that provides desired expansion / elongation / Poisson's ratio performance. The stent-like framework may also provide improved kink resistance / performance, even at very small diameters and very small wall thicknesses.

[0014] The sheath tube of embodiments of the present invention has insertion body and hub seat, and wherein said insertion body is elongated, and is configured to be advanced into patient, as into femoral artery.Sheath tube can have outer elastic layer, inner lining layer and the stent-like framework between inner layer and outer layer, and can also have adhesive so that layer / framework is fixed together.Stent-like framework can be configured to extend radially locally in response to the local surface of stent-like framework, and / or extend locally in response to local radial extension.Sheath tube can be configured to receive conduit slidably therein (as the delivery conduit with implant thereon), and extend radially locally and extend in response to the conduit being slidably advanced through sheath tube.

[0015] The stent sample framework of sheath can have multiple circumferential links, multiple nodes and multiple longitudinal links, wherein multiple annular elements extend around the circumference of stent sample framework, and each annular element comprises the circumferential links that alternate with nodes and extend circumferentially around the annular element.Adjacent annular elements can be fixed to each other via longitudinal links, and this longitudinal links longitudinally extend between the nodes of adjacent annular elements and connect the nodes of adjacent annular elements.Under the unexpanded and unstretched configuration of stent sample framework, longitudinal links and circumferential links have a more curved shape, and under the expansion and elongated configuration of stent sample framework, longitudinal links and circumferential links have a less curved shape.

[0016] The expansion of the stent-like framework can cause the circumferential links to at least partially straighten, which causes the nodes to at least partially rotate, which causes the longitudinal links to at least partially straighten. The elongation of the stent-like framework can cause the longitudinal links to at least partially straighten, which causes the nodes to at least partially rotate, which causes the circumferential links to at least partially straighten.

[0017] A system for delivering a prosthetic heart valve within a patient's native annulus according to an embodiment of the present invention includes an introducer sheath, a delivery catheter configured to be advanced through an internal blood vessel of the patient, and an implant secured to the delivery catheter.

[0018] The method of the present invention for treating a patient (such as by delivering a heart valve repair implant into the patient's heart) may include: creating an incision in the patient leading from an access site on the patient's outer skin surface into a first blood vessel; advancing the distal end of an access sheath through the incision and into the first blood vessel, wherein the access sheath is configured to locally radially expand and locally elongate when the catheter and implant are advanced therethrough; advancing a guidewire from the access site through the incision and the access sheath and the first blood vessel and to a position at or adjacent to the treatment site; advancing the distal end of the catheter along the guidewire to the treatment site, wherein advancing the catheter includes locally expanding and locally elongating the access sheath in response to advancement of the catheter therethrough; applying treatment at the treatment site via the catheter; removing the catheter from the patient; removing the guidewire from the patient; removing the access sheath from the patient; and closing the incision. The first blood vessel may be a femoral artery, and the distal end of the access sheath may be advanced into the aorta. The treatment site may be at or adjacent to a heart valve. The catheter may be a delivery catheter having a prosthetic heart valve at the distal end of the catheter. Local elongation of the access sheath can be caused by tension applied longitudinally to the access sheath by advancement of the catheter, and local expansion of the access sheath is caused by local elongation of the access sheath. The systems, devices and / or methods of the present invention can be used in various catheter-based procedures, including minimally invasive procedures and percutaneous procedures. In some embodiments, the method / system / device can involve transapical delivery performed through a small chest incision. In other embodiments, the method / system / device can be used in a transatrial procedure. In yet other embodiments, the method / system / device can be used in a percutaneous procedure, such as via one or more catheters that enter the patient's arterial system (e.g., through the femoral or brachial artery).

[0019] It should be understood that each element disclosed herein can be used in conjunction with any and all elements disclosed herein, even if a specific element combination is not explicitly shown in the drawings herein. In other words, based on the description of a specific device, a person skilled in the art will easily combine the features of a certain device in two such devices. Therefore, it should be understood that multiple elements are interchangeable and the present invention covers all arrangements thereof.

[0020] Other objects, features and advantages of the present invention will become apparent by reference to the following detailed description. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] Figure 1 is a side view of a system for delivering a device to a location in a patient via a catheter according to an embodiment of the present invention;

[0022] Figure 2A and 2B depicts a side view and an end view (in cross-section) of a sheath according to an embodiment of the present invention;

[0023] Figures 3A-3C depicts a side view of a system during transcatheter device delivery through a sheath according to an embodiment of the present invention;

[0024] Figure 4A and 4B depicts a perspective view of a stent-like framework according to an embodiment of the present invention;

[0025] Figure 5A Describes including Figure 4A and 4B A side view of a sheath of a stent-like framework of the framework depicted in;

[0026] Figure 5B Depicted Figure 5A a side view of a sheath of FIG. 1 and a delivery catheter being advanced therethrough;

[0027] Fig. 6A and 6B Depicting the operational features of a node portion of a stent-like framework for a sheath according to an embodiment of the present invention; and

[0028] Figures 7A-7C A stent-like framework portion is depicted in an unexpanded state, a partially expanded state, and a fully expanded state, respectively, according to an embodiment of the present invention. DETAILED DESCRIPTION

[0029] Figure 1 A system 10 according to the present invention is illustrated for delivering and deploying a prosthetic heart valve 12 or other medical device at a desired site in a patient. The system 10 includes a delivery catheter 14 (e.g., a balloon catheter) having a prosthetic heart valve thereon being advanced through a delivery sheath 16. In general, the sheath 16 is passed through an incision 18 in the patient and into a blood vessel 22 (e.g., a transfemoral vessel) such that a distal end 24 of the sheath 16 is inserted into the blood vessel 22. The sheath 16 may include a hub 26 at a proximal end 28 of the sheath, wherein the hub 26 contains a hemostasis valve 30 to prevent loss of bodily fluids through the hub 26. The delivery catheter 14 having the prosthetic valve 12 thereon may be inserted into the sheath 16 and advanced through the sheath 16 to advance and position the prosthetic device 12 at a desired treatment location in the patient. Figure 2A -2C depicts a sheath 16 according to an embodiment of the present invention. The sheath 16 has a distal end 24 and a proximal end 28, as well as an elongated insertion body 32 and a hub 26. A sheath lumen 34 passes through the sheath 16 from the proximal end 28 to the distal end 24.

[0030] The elongated insertion body 32 of the sheath 16 can be formed by a multi-layer structure. In the depicted embodiment, a low-friction liner 36 (such as PTFE, FEP, PEBAX, etc., which can be compounded with a lubricating material, for example, PEBAX and PROPEL) is provided to define the wall of the sheath lumen 34. The low-friction liner 36 promotes the advancement of catheters and other devices through the sheath 16. A layer of adhesive 38, such as a bonding layer adhesive, can be provided. The stent-like frame 40 can provide the desired expansion / contraction properties. The elastomeric sheath 42 can surround the outside of the sheath. Note that with respect to the liner 36, adhesive 38, stent-like frame 40 and sheath 42, the insertion body 32 according to the present invention can include all of these elements, exclude these elements, or include any combination of these elements. For example, a stent-like frame 40 can be used, but the inner liner 36, adhesive 38 and / or outer sheath / liner 42 are not used. The entire insertion body 32 is configured so that it can be locally expanded in a radial manner while still maintaining an overall insertion body length of a constant length - by causing the local surface length of the wall portion of the insertion body 32 to extend to accommodate the local deformation of the wall portion caused by the radial expansion. The insertion body 32 can preferably have a length 44 that is sufficient to allow the sheath distal end 24 to extend to a desired location in the patient (e.g., a desired location in a blood vessel, such as in the ascending aorta when accessed via a transfemoral approach) while the hub 26 remains outside the patient's body.

[0031] Lengths 44 within the scope of the present invention include 12-18 inches (30-45cm), 14-16 inches (35 to 40cm), etc. (for transfemoral approach), although other lengths are also within the scope of the present invention depending on the specific application. The insertion body 32 can have an initial outer diameter 46A small enough to easily fit through the access point, the target vessel (e.g., the aorta), and any intermediate body features (e.g., the femoral artery). For transfemoral procedures, the initial (unexpanded) outer diameter within the scope of the present invention includes 3-8mm, but other lengths are also within the scope of the present invention depending on the specific application. During the expansion process, the outer diameter of the sheath can potentially expand by 20% (or more), 30% (or more), 40% (or more), or even 50% (or more).

[0032] Figures 3A-3C A sheath 16 according to the present invention is depicted having an insertion body portion 32 that partially expands radially and longitudinally during catheter advancement while maintaining the same overall insertion body length 44. Figure 3A As shown in FIG. 1 , the insertion body portion 32 of the sheath 16 has a diameter 46 and an overall length 44 before the catheter and implant are advanced through the sheath 16. When the delivery catheter 14 with the implant 12 (e.g., a prosthetic heart valve) thereon is advanced through the sheath 16, as shown in FIG. Figure 3BAs shown in the figure, the insertion body portion 32 around the implant 12 is locally expanded in a radial manner. As the sheath / insertion body portion 32 is expanded, the compressive force of the sheath / insertion body portion is reduced during the radial expansion process due to the negative Poisson's ratio of the stent-like framework 40. This reduction in compressive force means that the sheath has less resistance to the advancement of the catheter / implant through the sheath.

[0033] The local radial expansion results in contour deformations along the outer surface of the insertion body portion 32 (such as at the "shoulders" 48 created on the insertion body portion 32 on either side of the implant 12). These surface deformations will result in an overall shortening of the sheath if they are not accompanied by local surface elongation of the outer surface of the sheath. Figure 3B As shown in , the local surface elongation provides a surface distance or profile length 50 (i.e., the distance along the surface of the insertion body portion) that is longer than the overall "cushion" length 44 of the sheath insertion portion 32. As a result, the overall length 44 of the sheath insertion portion 32 remains constant while the surface distance / profile length 50 of the sheath surface changes to accommodate radial expansion of the sheath 16. Figure 3C As shown in , after the catheter and implant are removed from the sheath 16, the insertion portion 32 returns to its original diameter.

[0034] Figure 4A-4B A stent-like framework 40 for a sheath 16 is shown in accordance with an embodiment of the present invention. The stent-like framework 40 has a series of circumferentially extending links 50 having circumferential link ends 52 secured to nodes 54 to form annular elements 55 extending radially around the stent-like framework, and longitudinally extending links 56 having longitudinal link ends 58 secured to nodes 54 such that the longitudinally extending links 56 connect adjacent annular elements 55. Each node is secured to a total of four (4) links, with two (2) circumferential link ends 52 secured to opposite sides of each node 54 and two (2) longitudinal link ends 58 secured to opposite sides of each node 54. The specific configuration of the nodes 54 and the links 50, 52 can produce a framework 40 in which local radial expansion inherently results in a corresponding local surface length extension, and in which the configuration causes the stent-like framework 40 to return to its original surface length when it returns to its original diameter. The reverse is also true, in which the specific configuration of the nodes 54 and the links 50, 52 can produce a framework 40 in which local surface elongation inherently results in a corresponding local radial expansion, and in which the configuration causes the stent-like framework 40 to return to its original diameter when it returns to its original surface length.

[0035] Figure 4A-4BThe embodiment of is only one example of a specific geometry according to the present invention. Note that other stent-like frame configurations that achieve a desired negative Poisson's ratio are also within the scope of the present invention. Moreover, the stent-like frame of the present invention can be formed from a variety of materials. For example, the frame 40 can be formed from a memory material (such as Nitinol) that allows the sheath to expand / elongate locally in response to the outward pressure caused by the catheter and implant being advanced through the sheath, and then return to its original diameter / local surface length after the catheter / implant has left the sheath.

[0036] Figure 5A and 5B An insertion portion 32 of the sheath 16 is depicted, which includes a stent-like framework 40, such as Figure 4A-4B , wherein the other layers in this embodiment (e.g., inner liner 36, elastomeric sheath 42, etc.) are depicted as relatively transparent so that the frame 40 is visible. When the delivery catheter 14 and the implant 12 are advanced through the sheath 16, as shown Figure 5B As shown in FIG. 1 , the insertion portion 32 and the stent-like framework 40 are locally deformed, including locally radially expanding and elongating, to accommodate the catheter 14 and the implant 12 while maintaining the overall sheath length.

[0037] The operational features of the overall node and link design of the present invention relate to the specific interactions between the respective links and nodes. Fig. 6A As shown in , prior to local expansion and elongation, the circumferential links 50 and longitudinal links 56 have significant curvature (curves). If a radially outward force or other force causes radial expansion, the circumferential links 50 are stretched to a less curved / straighter configuration as the radial expansion occurs. As the circumferential links 50 are stretched and straightened, the circumferential link ends 52 transmit forces to the nodes 54 and cause a rotational torque on the nodes 54. The rotational torque causes the nodes 54 to rotate through an angle 60, which in turn causes the rotational torque to be transmitted through the nodes 54 and to the longitudinal link ends 58 to also rotate, thereby causing the longitudinal links 56 to at least partially straighten. The at least partial straightening of the longitudinal links 56 causes the local surface of the stent structure to elongate, as shown in FIG. Figure 6B . Similarly, if a longitudinal tensile force or other elongation-inducing force causes local surface elongation, as the surface elongation occurs, the longitudinal links 56 are stretched to a less curved / straighter configuration. As the longitudinal links 56 are stretched and straightened, the longitudinal link ends 58 transmit forces to the nodes 54 and cause a rotational moment on the nodes 54. This rotational moment causes the nodes 54 to rotate through an angle 60, which in turn causes a rotational moment to be transmitted through the nodes 54 and to the circumferential link ends 52 to also rotate, thereby causing the circumferential links 50 to at least partially straighten. The at least partial straightening of the circumferential links 50 causes local radial expansion of the stent structure, as shown in FIG. Figure 6B as shown in .

[0038] Note that the angle 60 through which the node rotates can be relatively large. For example, the angle can be 30 to 60 degrees, 30 to 90 degrees, 30 degrees (or more), 45 degrees (or more), 60 degrees (or more), or even 90 degrees (or more).

[0039] like Figures 7A-7C The particular stent-like frame portion 70 shown in FIG. 1 includes longitudinal links 72 having thinner central portions 74 and wider end portions 76, where the links are secured to nodes 78. Similarly, circumferential links 82 have thinner central portions 84 and wider end portions 86, where the links are secured to nodes 78. The combination of the thinner central portions and wider end portions makes it easier for the links 72, 82 to bend into a straighter form at their central portions 74, 84, while making it more difficult for the links 72, 82 to bend at or adjacent the end portions 76, 86, where the links 72, 82 are secured to the nodes 78. As a result, rotational moments are more easily transmitted into and out of the nodes 78 via the links 72, 82 as the links straighten.

[0040] The node 78 according to the present invention may include an internal cutout, such as Figures 7A-7C Circular cutouts 88 are depicted in FIG. Circular cutouts 88 reduce the mass of the nodes 78 and the overall stent framework. The reduction in node mass reduces the moment of inertia of each node 78, making it easier for each node 78 to rotate and transfer the rotational moment from the circumferential links 82 to the longitudinal links 72, and vice versa.

[0041] exist Fig. 7A 4 shows a stent-like frame 40 in its pre-expanded, pre-stretched form. Note that the stent-like frame can be formed in a variety of ways, such as by laser cutting or otherwise cutting from a tube (such as a metal tube, e.g., a nitinol tube). When a portion of the stent-like frame is expanded, such as Figure 7B As shown in , the straightening of the circumferential links 82 causes the nodes 78 to rotate and thereby causes the longitudinal links 72 to bend to a straighter configuration. Similarly, when a portion of the stent-like framework is extended, such as Figure 7B As shown in , the straightening of the longitudinal links 72 causes the nodes 78 to rotate and thereby causes the circumferential links 82 to bend to a straighter configuration. Figure 7C As shown in , when fully extended, the nodes 78 are rotated even further, and the circumferential links 82 and longitudinal links 72 are almost completely straight - resulting in a local radial expansion combined with a proportional local surface elongation.

[0042] Various methods for treatment, including advancing a catheter into position via a sheath, are within the scope of the present invention. A preferred method (e.g., when treating an aortic valve) is a transcatheter approach via the femoral artery. The method may include the deployment of a transcatheter aortic valve replacement (TAVR), which may be performed using the same transcatheter approach.

[0043] In one example of a procedure for deploying a prosthetic aortic heart valve according to the present invention, femoral artery access is achieved via an access sheath of the present invention that is sized for a TAVR procedure. An incision leading to an internal blood vessel (such as a femoral artery) is created in the patient. The distal end of the access sheath is advanced through the incision and the femoral artery and reaches the desired position in the aorta, and the hub is positioned adjacent to the incision / access site just outside the patient. The guidewire is advanced from the femoral access site through the aortic arch and into the patient's left ventricle. The steerable shaft of the imaging catheter and / or delivery catheter can be advanced over the guidewire, such as via standard over-the-wire technology, to advance the distal end of the device to the target location. For example, the device can have a guidewire cavity. Echo and / or fluoroscopy and / or other visualization techniques and electrophysiology 3D mapping techniques can be used. Treatment and / or implant deployment can be performed, for example, by deploying a prosthetic heart valve at a target location. After proper deployment is confirmed, the catheter may be removed from the patient, the guidewire may be removed from the patient, the sheath may be removed from the patient, and the incision(s) may be closed, such as via sutures.

[0044] Note that each element of each embodiment disclosed herein and its corresponding element can be used in conjunction with any other embodiment disclosed herein and its corresponding element.

[0045] All dimensions listed are by way of example, and devices according to the invention may have dimensions outside those specific values ​​and ranges. The size and shape of the device and its elements depend on the specific application.

[0046] Unless otherwise specified, all technical and scientific terms used herein have the same meaning as those commonly understood by ordinary technicians in the field to which the present disclosure belongs. In order to facilitate reading of various embodiments of the present disclosure, the following terminology is provided:

[0047] Unless the context clearly indicates otherwise, the singular terms "a", "an", and "the" include plural references. Unless the context clearly indicates otherwise, the term "or" refers to a single element or a combination of two or more elements of the stated option elements.

[0048] The term "comprising" means "including". For example, a device comprising or containing A and B contains A and B, but may optionally contain C or other components in addition to A and B. In addition, a device comprising or containing A or B may contain A or B or A and B, and optionally one or more other components, such as C.

[0049] The term "subject" refers to humans and other animal subjects. In certain embodiments, the subject is a human or other mammal, such as a primate, cat, dog, cow, horse, rodent, sheep, goat or pig. In a specific example, the subject is a human patient.

[0050] Although methods and materials similar to or equivalent to those described herein can be used in the practice or testing of the present disclosure, suitable methods and materials are described below. In the event of a conflict, the present specification (including terminology) shall prevail. In addition, the materials, methods and examples are exemplary only and are not intended to be limiting.

[0051] Note that various independent features of the methods and systems of the present invention may be described in only one exemplary embodiment herein. The specific selection described herein with respect to a single exemplary embodiment shall not be construed as limiting the specific feature to apply only to the embodiment in which it is described. All features described herein are equally applicable to, superimposable on, or interchangeable with any or all other exemplary embodiments described herein, and in any combination or grouping or arrangement. In particular, the use of a single reference number herein to illustrate, define, or describe a specific feature does not mean that the feature cannot be combined or equivalent with other features in other figures or descriptions. Further, where two or more reference numbers in a figure or drawings are used, this should not be interpreted as being limited to only those embodiments or features, which are equally applicable to similar features, or not using one reference number, or omitting another reference number.

[0052] In view of the fact that the principles of the invention disclosed herein are applicable to a variety of possible embodiments, it should be recognized that the illustrated embodiments are merely examples of the invention and should not be considered to limit the scope of the invention. On the contrary, the scope of the invention is defined by the appended claims. Therefore, we claim that all inventions that fall within the scope and spirit of these claims are our inventions.

Claims

1. A delivery sheath (16), comprising: A tubular insertion body (32), the tubular insertion body (32) comprising an outer elastic layer, an inner lining layer and a stent-like frame (40) between the inner layer and the outer layer, the stent-like frame extending longitudinally along the tubular insertion body, wherein the stent-like frame comprises a plurality of circumferentially extending links (50), a plurality of nodes (54) and a plurality of longitudinally extending links (56), wherein the stent-like frame (40) comprises a plurality of annular elements (55), each annular element (55) extending around the circumference of the stent-like frame (40), each annular element (55) comprising the plurality of circumferentially extending links (50) alternating with the plurality of nodes (54), a longitudinally extending link of the plurality of longitudinally extending links extending between two nodes (54) of two adjacent annular elements, wherein the stent-like frame (40) is configured so that a local radial expansion of a portion thereof is proportional to a local surface elongation of the portion thereof, wherein in the unexpanded configuration of the portion of the stent-like frame (40), the longitudinally extending links (56) and the circumferentially extending links (50) in the portion of the stent-like frame (40) have a relatively curved shape, and in the expanded configuration of the portion of the stent-like frame (40), the longitudinally extending links (56) and the circumferentially extending links (50) in the portion of the stent-like frame (40) have a relatively uncurved shape, and wherein the stent-like framework (40) is configured such that local expansion of the stent-like framework (40) will cause one or more of the circumferentially extending links (50) to at least partially straighten, which will cause one or more of the nodes (54) to at least partially rotate, which will cause one or more of the longitudinally extending links (56) to at least partially straighten; Hub seat (26).

2. The delivery sheath (16) of claim 1, wherein the insertion body (32) comprises an outer layer (42) positioned on an outer surface of the stent-like framework (40).

3. The delivery sheath (16) of claim 1 or claim 2, wherein the insertion body (32) comprises an inner layer (36) positioned on an inner surface of the stent-like framework (40).

4. The delivery sheath (16) of claim 1, wherein the stent-like framework (40) is configured to maintain a constant overall linear length during local surface elongation or local expansion of the stent-like framework (40).

5. The delivery sheath (16) of claim 1 or claim 4, wherein the stent-like framework (40) is configured to locally radially expand in response to a local surface elongation of the stent-like framework (40).

6. The delivery sheath (16) of claim 1 or claim 4, wherein the stent-like framework (40) is configured to locally surface elongate in response to a local radial expansion of the stent-like framework (40).

7. The delivery sheath (16) of claim 1, wherein each of the plurality of longitudinally extending links (56) comprises a thinner central portion (74) and a plurality of wider end portions (76).

8. A delivery sheath (16) according to claim 1, wherein the stent-like frame (40) is configured so that local surface elongation of the stent-like frame (40) will cause one or more of the longitudinally extending links (56) to at least partially straighten, which will cause one or more of the nodes (54) to at least partially rotate, which will cause one or more of the circumferentially extending links (50) to at least partially straighten.

9. A system for delivering a prosthetic heart valve within a native annulus of a patient, comprising: The delivery sheath (16) according to claim 1; a delivery catheter (14) configured to be advanced through an internal blood vessel of a patient; and an implant (12), the implant (12) being secured to the delivery catheter (14); The delivery sheath (16) is configured to slidably receive the delivery catheter (14) with the implant (12) thereon, and to locally radially expand and elongate in response to the delivery catheter (14) with the implant (12) thereon being slidably advanced through the delivery sheath (16).

10. A system according to claim 9, wherein the stent-like frame (40) is configured so that elongation of the stent-like frame (40) will cause one or more of the longitudinal links (56) to at least partially straighten, which will cause one or more of the nodes (54) to at least partially rotate, which will cause one or more of the circumferential links (50) to at least partially straighten.

11. A system according to claim 9 or claim 10, wherein the stent-like frame (40) is configured so that when a portion of the stent-like frame (40) undergoes local surface elongation and local expansion, the portion of the stent-like frame (40) will maintain a constant linear length.

12. The system of claim 11, wherein the stent-like frame (40) is configured such that local surface elongation of the portion of the stent-like frame (40) does not change the overall linear length of the stent-like frame (40).